[Federal Register Volume 65, Number 75 (Tuesday, April 18, 2000)]
[Notices]
[Page 20824]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9608]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability and Injury Prevention and Control Special 
Emphasis Panel: Human Immunodeficiency Virus Prevention Projects for 
Community-Based Organizations, Program Announcement #00023

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Disease, Disability and Injury Prevention and Control 
Special Emphasis Panel: Human Immunodeficiency Virus Prevention 
Projects for Community-Based Organizations, Program Announcement 
#00023.
    Times and Dates: 9 a.m.-9:15 a.m., April 14, 2000 (Open); 9:15 
a.m.-12 p.m., April 14, 2000 (Closed).
    Place: This meeting will be conducted in two separate, 
simultaneous conference call sessions. To participate, please dial 
1-800-713-1971 and when prompted, enter participant code #848941, 
and 1-800-713-1971 and when prompted, enter participant code 
#868508. The call will only be open to the public for the first 
fifteen minutes, after which the review process will begin.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of five applications received in response 
to Program Announcement #00023. These five applications were 
originally deemed ineligible, however, after careful 
reconsideration, it was determined that they should be given the 
same consideration as applications reviewed during the original SEP 
meeting that took place March 20-24, 2000.
    Contact Person for More Information: Megan Foley or Beth Wolfe, 
Prevention Support Office, National Center for HIV, STD, and TB 
Prevention, CDC, Corporate Square Office Park, 11 Corporate Square 
Boulevard, M/S E07, Atlanta, Georgia 30329, telephone 404/639-8025, 
e-mail <a href="/cdn-cgi/l/email-protection#6d20372b5e2d0e090e430a021b"><span class="__cf_email__" data-cfemail="df928599ec9fbcbbbcf1b8b0a9">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#3b7e746c0a7b585f58155c544d"><span class="__cf_email__" data-cfemail="45000a1274052621266b222a33">[email protected]</span></a>.
    This notice is being published less than 15 days in advance of 
the meeting due to administrative oversight and program delays. The 
Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: April 12, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 00-9608 Filed 4-13-00; 11:52 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>